Gadobenate dimeglumine-enhanced liver MR imaging in cirrhotic patients: quantitative and qualitative comparison of 1-hour and 3-hour delayed images

J Magn Reson Imaging. 2011 Apr;33(4):889-97. doi: 10.1002/jmri.22492.

Abstract

Purpose: To compare the image quality and diagnostic performance of 1- and 3-h delayed-phase MR images (DPIs) after gadobenate dimeglumine injection in detecting small hepatocellular carcinomas (HCCs) in cirrhotic patients.

Materials and methods: Relative enhancement of the liver (RE(liver) ) and HCC (RE(HCC) ) and liver-to-lesion contrast-to-noise ratio (CNR) of HCC were measured quantitatively on 1- and 3-h DPIs in 65 patients with 88 HCCs. For qualitative analysis, two radiologists independently evaluated three image sets in 19 patients with 25 HCCs ≤ 2 cm and in 16 controls without HCCs: conventional liver MR without DPI (set A), adding 1-h DPI (set B), and adding 3-h DPI (set C), using a 5-point scale for diagnosing small HCCs. Diagnostic performance for small HCCs was analyzed using the alternative free-response receiver operating characteristic method.

Results: Mean RE(liver) (P = 0.013) and RE(HCC) (P < 0.001) were significantly higher on 1-h than on 3-h DPI, whereas CNR was significantly higher on 3-h than on 1-h DPI (P = 0.001). Observer-averaged figure of merit (FOM) was significantly higher for set C than for set A (0.942 versus 0.883; P = 0.013).

Conclusion: In cirrhotic patients, 3-h DPI provides a higher liver-to-lesion contrast and a better diagnostic performance for small HCCs than 1-h DPI.

MeSH terms

  • Adult
  • Aged
  • Contrast Media / pharmacology*
  • Female
  • Fibrosis / diagnosis*
  • Fibrosis / pathology
  • Humans
  • Image Processing, Computer-Assisted
  • Liver / pathology
  • Liver Neoplasms / diagnosis
  • Liver Neoplasms / pathology*
  • Magnetic Resonance Imaging / methods*
  • Male
  • Meglumine / analogs & derivatives*
  • Meglumine / pharmacology
  • Middle Aged
  • Organometallic Compounds / pharmacology*
  • ROC Curve
  • Retrospective Studies
  • Time Factors
  • Treatment Outcome

Substances

  • Contrast Media
  • Organometallic Compounds
  • gadobenic acid
  • Meglumine